Autism Biomarkers Consortium for Clinical Trials (ABC-CT)

The Autism Biomarkers Consortium for Clinical Trials (ABC-CT) is seeking families to participate in a study to improve diagnosis and treatment in Autism Spectrum Disorder (ASD). We are currently recruiting both typically developing children and children with a diagnosis of ASD between the ages of 6 and 11 years old. Using EEG to measure brain function, eye tracking technology to measure visual attention, and automated recording techniques to assess behavior and speech, children will be monitored over a 6-month period. This community resource will also include DNA samples from children with ASD and their parents for use in future genetic studies. To learn more, please contact our research coordinator at (206) 221-7688 or abcct@uw.edu.

The CLOUDS Study

The CLOUDS Study is inviting children ages 7- to 10-year olds with and without autism to the University of Washington to participate in a research study. Researchers at the UW Bloedel Hearing Research Center want to learn about how the brain helps us listen in noisy real-world environments. This study consists of two 3 hour visits and will include an EEG recording, developmental assessments, a hearing screening, and a parent questionnaire. Eligible participants would be compensated $100 for their time, parking reimbursement, and a summary report. To learn more, please contact our research coordinator at (206) 616-2041 or landlab@uw.edu.

Fragile X Study via Zoom

Help us understand how children learn, with a focus on autism spectrum disorder and fragile X syndrome! Participation is from home via Zoom.  Click here for flyer/more info!

This research addresses how children learn – in this case, how children learn new vocabulary words in stories and how memory and attention relate to new learning! We are seeking children with autism (ages 5-10), fragile X syndrome (ages 5-10), or no developmental disabilities (ages 2-6).